Deeplife Raises $10M to Revolutionize Drug Discovery Using Digital Cell Twins

Deeplife startup, a pioneer in the application of generative artificial intelligence to biology, announces the successful closing of a $10M Series A fundraising round. This round was led by YZR Capital and Relyens Innovation Santé and historical investors such as Paris Business Angels.

Read the press release